Screening compound: InChI=1S/C19H17ClN4O2/c20-15-6-8-16(9-7-15)24-18(14-4-2-1-3-5-14)21-17(22-24)19(25)23-10-12-26-13-11-23/h1-9H,10-13H2

Screening compound: InChI=1S/C19H17ClN4O2/c20-15-6-8-16(9-7-15)24-18(14-4-2-1-3-5-14)21-17(22-24)19(25)23-10-12-26-13-11-23/h1-9H,10-13H2
Screening compound: InChI=1S/C19H17ClN4O2/c20-15-6-8-16(9-7-15)24-18(14-4-2-1-3-5-14)21-17(22-24)19(25)23-10-12-26-13-11-23/h1-9H,10-13H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C19H17ClN4O2/c20-15-6-8-16(9-7-15)24-18(14-4-2-1-3-5-14)21-17(22-24)19(25)23-10-12-26-13-11-23/h1-9H,10-13H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D351-2134

Molecular Formula

C19H17ClN4O2 (C19 H17 ClN4 O2)

Compound Name

4-[1-(4-chlorophenyl)-5-phenyl-1H-1,2,4-triazole-3-carbonyl]morpholine

IUPAC name

4-[1-(4-chlorophenyl)-5-phenyl-1H-124-triazole-3-carbonyl]morpholine

SMILES

O=C(c(nc1-c2ccccc2)nn1-c(cc1)ccc1Cl)N1CCOCC1

InChI

InChI=1S/C19H17ClN4O2/c20-15-6-8-16(9-7-15)24-18(14-4-2-1-3-5-14)21-17(22-24)19(25)23-10-12-26-13-11-23/h1-9H,10-13H2

InChI Key

DZZIBRAWTXCIBF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD03068899

InChI=1S/C19H17ClN4O2/c20-15-6-8-16(9-7-15)24-18(14-4-2-1-3-5-14)21-17(22-24)19(25)23-10-12-26-13-11-23/h1-9H,10-13H2 in Drug Discovery

Included in Screening Libraries

Cardiovascular Library (22201 compounds)

PI3K-Targeted Library (17255 compounds)

SH2 Library (10483 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Endocrine
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with InChI=1S/C19H17ClN4O2/c20-15-6-8-16(9-7-15)24-18(14-4-2-1-3-5-14)21-17(22-24)19(25)23-10-12-26-13-11-23/h1-9H,10-13H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C19H17ClN4O2/c20-15-6-8-16(9-7-15)24-18(14-4-2-1-3-5-14)21-17(22-24)19(25)23-10-12-26-13-11-23/h1-9H,10-13H2?
Check Price and Availability of InChI=1S/C19H17ClN4O2/c20-15-6-8-16(9-7-15)24-18(14-4-2-1-3-5-14)21-17(22-24)19(25)23-10-12-26-13-11-23/h1-9H,10-13H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C19H17ClN4O2/c20-15-6-8-16(9-7-15)24-18(14-4-2-1-3-5-14)21-17(22-24)19(25)23-10-12-26-13-11-23/h1-9H,10-13H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C19H17ClN4O2/c20-15-6-8-16(9-7-15)24-18(14-4-2-1-3-5-14)21-17(22-24)19(25)23-10-12-26-13-11-23/h1-9H,10-13H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C19H17ClN4O2/c20-15-6-8-16(9-7-15)24-18(14-4-2-1-3-5-14)21-17(22-24)19(25)23-10-12-26-13-11-23/h1-9H,10-13H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C19H17ClN4O2/c20-15-6-8-16(9-7-15)24-18(14-4-2-1-3-5-14)21-17(22-24)19(25)23-10-12-26-13-11-23/h1-9H,10-13H2 available by request